Lava Therapeutics Funding: $83M Raised, Series C (2020)
Lava Therapeutics is based in Utrecht, The Netherlands and Philadelphia. It has raised $83M in total funding. Latest round: Series C.
Lava Therapeutics funding overview
Lava Therapeutics is based in Utrecht, The Netherlands and Philadelphia. Lava Therapeutics has raised $83M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in September 2020. The round record for Lava Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include Novo Ventures, Sanofi Ventures, Redmile Group, Ysios Capital, BB Pureos Bioventures, Versant and 2 others. 8 distinct backers are named across the disclosed rounds.
Lava Therapeutics at a glance
Total raised
$83M
Latest round
Series C
Latest round date
September 2020
Headquarters
Utrecht, The Netherlands and Philadelphia
Notable investors
Novo Ventures, Sanofi Ventures, Redmile Group, Ysios Capital, BB Pureos Bioventures, Versant, Gilde Healthcare, MRL Ventures Fund
Frequently asked about Lava Therapeutics funding
How much has Lava Therapeutics raised?
Lava Therapeutics has raised $83M in total disclosed funding across the rounds on record.
Who has invested in Lava Therapeutics?
Novo Ventures, Sanofi Ventures, Redmile Group, Ysios Capital, BB Pureos Bioventures, Versant are named among the investors backing Lava Therapeutics.
What was the latest Lava Therapeutics funding round?
The most recent disclosed round is a Series C, announced in September 2020.
Where is Lava Therapeutics based?
Lava Therapeutics is based in Utrecht, The Netherlands and Philadelphia.
When did Lava Therapeutics last raise?
The last disclosed Lava Therapeutics round closed in September 2020 at Series C.
Round data for Lava Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Utrecht and backer lists below.
